Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Journal of Hepatology|December 13, 2022
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitisLung-Yi Mak, Ed Gane, Christian Schwabe, et al.
Nature Medicine|July 21, 2025
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitisMaximilian Jara, Jenny Norlin, Mette Skalshøi Kjær, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 6, 2025
Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six CountriesJeffrey V Lazarus, Leire Agirre-Garrido, J Emilio Miralles-Sanchez, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
Diabetes Care|December 12, 2022
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023Nuha A ElSayed, Grazia Aleppo, Vanita R Aroda, et al.
Hepatology (Baltimore, Md.)|July 28, 2023
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)Mazen Noureddin, Emily Truong, Rebeca Mayo, et al.
The Lancet. Gastroenterology & Hepatology|December 9, 2023
Implementation of a liver health check in people with type 2 diabetesKushala W M Abeysekera, Luca Valenti, Zobair Younossi, et al.
Metabolism: Clinical and Experimental|June 21, 2020
Targeting pheochromocytoma/paraganglioma with polyamine inhibitorsSudhir Kumar Rai, Fernando Bril, Heather M Hatch, et al.
Nature Reviews. Gastroenterology & Hepatology|October 28, 2021
Advancing the global public health agenda for NAFLD: a consensus statementJeffrey V Lazarus, Henry E Mark, Quentin M Anstee, et al.
Annals of Hepatology|October 8, 2020
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver diseaseJuan Pablo Arab, Melisa Dirchwolf, Mário Reis Álvares-da-Silva, et al.
Pageof 19